Continuous Glucose Monitoring Beneficial in Type 2 Diabetes Not Treated With Insulin

NEJM study supports CGM use for people with diabetes who don’t take insulin

The results come as Dexcom is awaiting a decision from the Centers for Medicare and Medicaid Services to expand Medicare coverage of the devices for people with Type 2 diabetes.

Landmark Dexcom CONNECT Study Published in The New England Journal of Medicine, Redefining the Standard of Care for People with Type 2 Diabetes Not on Insulin

SAN DIEGO--(BUSINESS WIRE)--Oct 14, 2026-

Continuous Glucose Monitoring Beneficial in Type 2 Diabetes Not Treated With Insulin

(MedPage Today) -- Use of a continuous glucose monitor (CGM) reduced HbA1c levels in adults with type 2 diabetes not treated with insulin, the randomized CONNECT trial showed. Among 283 patients at primary care practices, mean HbA1c levels decreased...